Turkish Medical Association Urges Withdrawal of Medical Cannabis Bill

The Turkish Medical Association (TTB) has issued a strong warning against a new legislative proposal that would allow medical cannabis-based products to be sold in pharmacies across Türkiye. The proposal—submitted to Parliament by the AK Party on June 25—aims to regulate medical cannabis as part of a broader health legislation package. However, the TTB argues that the law risks paving the way for non-medical, recreational use and poses serious public health threats.

Medical Cannabis Regulation Sparks Scientific and Social Debate

In a detailed report prepared by the TTB Tobacco Control Working Group, the organization emphasized that cannabis remains one of the most widely abused illicit substances worldwide, with over 60 cannabinoid compounds—some of which can lead to severe psychiatric and physical health issues.

The group warned: “Opening a commercial channel without strict medical justification may lead to personal-use markets disguised as therapeutic products.”

THC vs. CBD: Health Risks and Unproven Benefits

The report explains that the two primary compounds in cannabis—THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol)—can have opposing effects. Prolonged or high-dose use of THC-rich products may trigger psychotic disorders, addiction, depression, and even suicidal behavior, according to the TTB.

While some countries have authorized limited use of cannabinoid therapies for specific symptoms, the TTB states there is insufficient scientific evidence supporting the long-term safety and efficacy of such treatments.

Common side effects include:

• Dizziness

• Cognitive impairment

• Hallucinations

• Dry mouth

Traffic Risk Elevated with Cannabis Use

Citing global traffic safety data, the report also highlights that non-medical cannabis use significantly increases accident risks. The likelihood of fatal crashes rises by 37%, and injury-related accidents by 96%, according to cited research.

“Bill Must Be Withdrawn to Protect Public Health”

The TTB calls for the withdrawal of the current legislative proposal, arguing that it may inadvertently create a quasi-legal cannabis market under the guise of healthcare. The group insists that no cannabis-related regulation should be passed without consultation from medical professionals, scientific institutions, and relevant ministries.

What the Bill Proposes

The bill titled “Amendments to Certain Health Laws and Decree Law No. 663” aims to legally permit the sale of cannabis-based medicinal products in Turkish pharmacies. AK Party Deputy Chair Leyla Şahin Usta, one of the bill’s key proponents, defended the proposal by stating:

“Cannabis is widely used in global healthcare. Türkiye must strengthen its competitive edge in this field. These products should not be confused with illicit drugs.”

Usta emphasized that the goal is to promote pharmaceutical innovation, not recreational use.